Flavia Sousa
Cited by
Cited by
Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles
P Fonte, S Soares, F Sousa, A Costa, V Seabra, S Reis, B Sarmento
Biomacromolecules 15 (10), 3753-3765, 2014
Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications
C Martins, F Sousa, F Araķjo, B Sarmento
Advanced Healthcare Materials 7 (1), 1701035, 2018
A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles
F Sousa, A Cruz, P Fonte, IM Pinto, MT Neves-Petersen, B Sarmento
Scientific reports 7 (1), 1-13, 2017
Oral films as breakthrough tools for oral delivery of proteins/peptides
PM Castro, P Fonte, F Sousa, AR Madureira, B Sarmento, ME Pintado
Journal of Controlled Release 211, 63-73, 2015
How to overcome the limitations of current insulin administration with new non-invasive delivery systems
F Sousa, P Castro, P Fonte, B Sarmento
Therapeutic delivery 6 (1), 83-94, 2015
Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?
F Sousa, P Castro, P Fonte, PJ Kennedy, MT Neves-Petersen, ...
Expert opinion on drug delivery 14 (10), 1163-1176, 2017
Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery
D Sgorla, A Lechanteur, A Almeida, F Sousa, E Melo, … Bunhak, ...
Expert opinion on drug delivery 15 (3), 213-222, 2018
Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology
RP Moura, C Martins, S Pinto, F Sousa, B Sarmento
Expert opinion on drug delivery 16 (3), 271-285, 2019
Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6
PJ Kennedy, F Sousa, D Ferreira, C Pereira, M Nestor, C Oliveira, ...
Acta biomaterialia 81, 208-218, 2018
Biophysical study of bevacizumab structure and bioactivity under thermal and pH-stresses
F Sousa, B Sarmento, MT Neves-Petersen
European Journal of Pharmaceutical Sciences 105, 127-136, 2017
Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells
I Pereira, F Sousa, P Kennedy, B Sarmento
International Journal of Pharmaceutics 549 (1-2), 397-403, 2018
Development and validation of a rapid reversed-phase HPLC method for the quantification of monoclonal antibody bevacizumab from polyester-based nanoparticles
F Sousa, VMF GonÁalves, B Sarmento
Journal of pharmaceutical and biomedical analysis 142, 171-177, 2017
Nanoparticles provide long-term stability of bevacizumab preserving its antiangiogenic activity
F Sousa, A Cruz, IM Pinto, B Sarmento
Acta biomaterialia 78, 285-295, 2018
Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules
PM Castro, F Sousa, R Magalh„es, VMP Ruiz-Henestrosa, AMR Pilosof, ...
Carbohydrate polymers 194, 411-421, 2018
Polyester-based nanoparticles for the encapsulation of monoclonal antibodies
F Sousa, P Fonte, A Cruz, PJ Kennedy, IM Pinto, B Sarmento
Recombinant glycoprotein production, 239-253, 2018
The solid progress of nanomedicine
JP Martins, J das Neves, M de la Fuente, C Celia, H Florindo, ...
Drug Delivery and Translational Research, 1-4, 2020
Extraction and characterisation of cellulose nanocrystals from pineapple peel
AR Madureira, T Atatoprak, D «abuk, F Sousa, RC Pullar, ME Pintado
International Journal of Food Studies, 2018
Therapeutic monoclonal antibodies delivery for the glioblastoma treatment
F Sousa, RP Moura, E Moreira, C Martins, B Sarmento
Advances in protein chemistry and structural biology 112, 61-80, 2018
Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles
F Sousa, HK Dhaliwal, F Gattacceca, B Sarmento, MM Amiji
Journal of Controlled Release 309, 37-47, 2019
Cell-based in vitro models for nasal permeability studies
F Sousa, P Castro
Concepts and Models for Drug Permeability Studies, 83-100, 2016
The system can't perform the operation now. Try again later.
Articles 1–20